Biotech China Company Profile

23:26 EST 15th December 2018 | BioPortfolio

News Articles [2849 Associated News Articles listed on BioPortfolio]

China's I-Mab Raises $220 Million in C Round for Biotech Development

China's I-Mab Biopharma completed a $220 million Series C round led by Hony Capital. It was, according to the company, one of the largest C rounds ever for an innovative China biotech. I-Mab was forme...

STAT Plus: Archived: A live chat discussing the rise of China as a biotech powerhouse

China once had a reputation for punching below its weight when it came to biotech. These days, however, the country is a rapidly growing hotbed for biopharma investment and activity.…

STAT Plus: Want to operate in China’s biotech scene? Here are five tips

“You need a China partner, in general, to commercialize your drugs in China.” And here’s what else you need to know:

Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China

Pacira Pharmaceuticals (NASDAQ:PCRX) has announced that it and Nuance Biotech have entered into an agreement with Nuance, a China-based speciality pharmaceutical company to advance the development and...

UPDATED-- JHL Biotech Announces China Approves Phase I and Phase III Clinical Trial Application ...

HSINCHU, Taiwan and WUHAN, China, Oct. 16, 2018 /PRNewswire/ -- JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved Read more...

Harbour BioMed signs $350m deal with Kelun-Biotech for ex-China rights to A167

The global partnership, which will exclude the Greater China region, is expected to fetch more than $350m to Kelun-Biotech in addition to royalties based on annual net sales. The post Harbour BioMed ...

Aim High And Keep Pushing: China Biotech Dealmakers Borrow Page From Trump

Recent biotech investment deals involving WuXi, Oncologie and Siranomics show Chinese investors are becoming increasingly bold and savvy in betting...   

Argentina could approve biotech soybeans from China

Argentina may soon approve commercial cultivation of biotech soybeans developed by China-based high-tech agriculture company  -More- 

Clinical Trials [924 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military

The purpose of this study is to assess the safety and immunogenicity of three seasonal trivalent influenza vaccines (TIVs)manufactured by Glaxosmith Kline (GSK), Beijing Sinovac Biotech (S...

Trevo® Retriever Registry (China)

Trevo® Retriever Registry (China) is to assess real world performance of the SDA cleared Trevo Retriever intended to restore blood flow in the neurovasculature by removing thrombus in pat...

Companies [1439 Associated Companies listed on BioPortfolio]

China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy ...

China Kangtai Cactus Biotech Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy ...

BiotechEast Co., Ltd.

Biotechnology in TaiwanWith the supporting infrastructure in place and with strong government backing, Taiwan is poised to become Asia's hub for the life sciences. A stepping stone to China, Taiwan is...

Biotech China

Sinovac Biotech

Sinovac Biotech Ltd. (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepat...

More Information about "Biotech China" on BioPortfolio

We have published hundreds of Biotech China news stories on BioPortfolio along with dozens of Biotech China Clinical Trials and PubMed Articles about Biotech China for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotech China Companies in our database. You can also find out about relevant Biotech China Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record